Asha Therapeutics
Julia Hallisey is the Chief Operating Officer and Director of Investor Relations at Asha Therapeutics, a life sciences company specializing in designing compounds for various diseases. Julia also held similar roles at Ibis Therapeutics, Venn Therapeutics, and Proclaim, showcasing their expertise in strategy, finance, and corporate development. With a background in investor relations and analytics, Julia has positioned multiple companies for sustainable growth. Julia holds a Master of Business Administration from Harvard Business School and a Bachelor of Arts in English Language and Literature from Smith College.
This person is not in any teams
This person is not in any offices
Asha Therapeutics
Asha Therapeutics utilizes a unique mito-centric approach to develop treatments for neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease, Myalgic Encephalomyelitis, and Chronic Fatigue Syndrome. Asha Therapeutics is advancing a new paradigm of drug discovery by re-engineering cellular machinery toward restoring thepowerhouse of the cell.